Join the 'Cialis' group to help and get support from people like you.

Cialis Blog

Cialis May Not Prevent Impotence in Men Treated for Prostate Cancer

Posted 17 days ago by Drugs.com

TUESDAY, April 1, 2014 – Taking the erectile dysfunction drug Cialis while receiving radiation therapy for prostate cancer doesn't seem to help men's sexual function after treatment, a new study finds. About 40 percent of men undergoing radiation therapy for prostate cancer suffer from erectile dysfunction afterward, according to the study. The researchers wanted to find out whether impotence could be prevented by having patients take Cialis (tadalafil) during the course of treatment. But there was very little difference in outcome when Cialis was compared to a placebo pill. "There is no indication to use Cialis in men about to undergo radiotherapy for prostate cancer," said lead researcher Dr. Thomas Pisansky, a professor of radiation oncology at the Mayo Clinic. "Cialis should be reserved for the treatment of erectile dysfunction if and when it occurs," he added. The report was ... Read more

Related support groups: Cialis, Prostate Cancer

Thousands of Dangerous Erection Cases Seen in ERs Each Year, Study Finds

Posted 2 Dec 2013 by Drugs.com

FRIDAY, Nov. 29 – A new study suggests that thousands of men seek care in U.S. emergency rooms each year for the painful condition known as priapism – an erection that lasts too long and threatens to permanently harm the penis. The researchers estimated that it costs $124 million a year on average to treat priapism at hospitals. "We're not talking about a massive problem, but it's more common than we thought," said study author Dr. Daniel Stein, chief resident with the urology department at the Northwestern University Feinberg School of Medicine. It's not clear how many of an estimated 10,000 cases annually are due to a side effect of Viagra and similar impotence drugs, but urologists say they've seen very few men suffering from the infamous four-hour-plus erections that TV ads warn about. Sickle cell disease actually may be responsible for a much higher number of cases. Stein said ... Read more

Related support groups: Viagra, Cialis, Levitra, Sildenafil, Tadalafil, Staxyn, Revatio, Adcirca, Vardenafil, Stendra, Avanafil, Priapism

FDA Medwatch Alert: SexVoltz, Velextra, and Amerect by Beomonstar Products: Recall - Undeclared Drug Ingredient

Posted 9 May 2013 by Drugs.com

ISSUE: BeaMonstar Products notified the public that it is recalling its SexVoltz, Velextra, and Amerect capsules to the retail level. Laboratory analysis conducted by the FDA on SexVoltz and Velextra has determined these products contain undeclared tadalafil. Amerect is voluntarily recalled because it has the potential to contain undeclared tadalafil. Tadalafil is an FDA-Approved drug used to treat male erectile dysfunction (ED), making the products unapproved new drugs. This undeclared active ingredient poses a threat to consumers because tadalafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. SexVoltz SKU’s 626570609490, 827912089028, 626570617877, 626570615316 Velextra SKU’s 626570619475, 626 ... Read more

Related support groups: Erectile Dysfunction, Cialis, Tadalafil, Adcirca

FDA Medwatch Alert: Bullet Proof: Public Notification - Undeclared Drug Ingredient

Posted 8 May 2013 by Drugs.com

ISSUE: FDA is advising consumers not to purchase or use “Bullet Proof,” a product promoted and sold for sexual enhancement on various websites and in some retail stores. FDA laboratory analysis confirmed that “Bullet Proof” contains tadalafil, the active ingredient in Cialis, an FDA-approved prescription drug for Erectile Dysfunction (ED).  This undeclared ingredient may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels.  Men with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. BACKGROUND: These products are typically promoted for sexual enhancement, weight loss, and body building, and are often represented as being “all natural.”  RECOMMENDATION:  Consumers should stop using this product immediately and throw it away.  Consumers who have experienced any negative side eff ... Read more

Related support groups: Erectile Dysfunction, Cialis, Tadalafil, Adcirca

FDA Medwatch Alert: American Lifestyle Vicerex and Black Ant Capsules: Recall - Undeclared Drug Ingredient

Posted 3 May 2013 by Drugs.com

ISSUE: May 1, 2013 - American Lifestyle is announcing that it is conducting a voluntary recall of all lots of Vicerex UPC 893490820087 and Black Ant UPC 4026666142546. Laboratory analysis conducted by the FDA has determined the Vicerex product contains undeclared tadalafil and the Black Ant product contains undeclared sildenafil. Tadalafil and sildenafil are FDA-Approved drugs used to treat male erectile dysfunction (ED), making the Vicerex and the Black Ant products unapproved new drugs. These undeclared active ingredients poses a threat to consumers because tadalafil and sildenafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. No Adverse events have been reported related to this recall. BACKGROUND: ... Read more

Related support groups: Viagra, Erectile Dysfunction, Cialis, Sildenafil, Tadalafil, Revatio, Adcirca

Impotence Drug Cialis Might Have Other Sexual Benefits: Study

Posted 30 Jan 2013 by Drugs.com

WEDNESDAY, Jan. 30 – Cialis, the erectile dysfunction medication known to help men get ready for sex, may also help encourage ejaculation and orgasm, a new study suggests. "There are many men who have, at most, very mild problems achieving an erection but who cannot easily ejaculate. Our study shows Cialis works very well for these men with problems ejaculating," lead researcher Dr. Darius Paduch, director of Sexual Health and Medicine at Weill Cornell Medical College in New York City, said in a college news release. In the study, which was funded by Cialis' maker, Eli Lilly and Company, Paduch's team analyzed data from 17 clinical trials involving men with erectile dysfunction and/or trouble ejaculating or achieving orgasm. The trials included almost 3,600 men averaging about 55 years of age. The men typically took Cialis for 12 weeks, at varying doses. As reported in the February ... Read more

Related support groups: Erectile Dysfunction, Cialis, Tadalafil, Adcirca, Sexual Deviations or Disorders

FDA Medwatch Alert: Mojo Nights and Mojo Nights for Her: Recall - Undeclared Drug Ingredient

Posted 21 Sep 2012 by Drugs.com

ISSUE: Evol Nutrition Associates, Inc./Red Dawn (“Evol Nutrition”) notified the public of a nationwide recall of all lots of two dietary supplement products distributed by the company under the names Mojo Nights and Mojo Nights for Her to the consumer level. Testing by the FDA revealed the presence of undeclared tadalafil and sildenafil in Mojo Nights (Evol Nutrition is also recalling Mojo Nights for Her). Tadalafil and sildenafil are active ingredients of FDA-approved drugs for Erectile Dysfunction (ED), making Mojo Nights an unapproved new drug. These undeclared active ingredients may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.  BACKGROUND: These two products were distributed nationwide via retail sto ... Read more

Related support groups: Viagra, Erectile Dysfunction, Cialis, Dietary Supplementation, Sildenafil, Tadalafil, Revatio, Adcirca

Viagra May Help Children With Rare Blood Pressure Disorder

Posted 25 Oct 2011 by Drugs.com

TUESDAY, Oct. 25 – New research suggests that the active ingredient in the erectile dysfunction drug Viagra, which was initially developed as a treatment for heart disease, could help children with a rare condition called pulmonary arterial hypertension. The drug, which is expensive to take regularly and has side effects, is already approved to treat the condition in adults. And some pediatricians use it to treat children, said Dr. Thomas Kulik, senior associate in cardiology at Children's Hospital Boston. But it has not yet received U.S. Food and Drug Administration approval for that purpose. Pulmonary arterial hypertension, a rare condition, causes abnormally high blood pressure in the arteries that lead to the lungs. It can be inherited, accompany some forms of heart disease or occur for no known reason, Kulik said. The disease can limit the ability to exercise and lead to heart ... Read more

Related support groups: Viagra, Cialis, Pulmonary Hypertension, Sildenafil, Tadalafil, Revatio, Adcirca

FDA Approves Cialis to Treat Benign Prostatic Hyperplasia

Posted 7 Oct 2011 by Drugs.com

October 6, 2011 – The U.S. Food and Drug Administration today approved Cialis (tadalafil) to treat the signs and symptoms of benign prostatic hyperplasia (BPH), a condition in which the prostate gland becomes enlarged, and for the treatment of BPH and erectile dysfunction (ED), when the conditions occur simultaneously. Cialis was approved in 2003 for the treatment of ED.Common symptoms of BPH include difficulty in starting urination and a weak urine stream; a sudden urge to urinate; and more frequent urination including at night. The severity of symptoms of BPH can be measured using the International Prostate Symptom Score (IPSS). In two clinical trials, men with BPH who took 5 milligrams (mg) of Cialis once daily experienced a statistically significant improvement in their symptoms of BPH compared to men who were treated with placebo. The trials based their findings on a reduction in ... Read more

Related support groups: Cialis, Benign Prostatic Hyperplasia (BPH), Tadalafil

FDA Approves Additional Use for Lilly's Cialis

Posted 7 Oct 2011 by Drugs.com

From Associated Press (October 6, 2011) SILVER SPRING, Md. – The Food and Drug Administration said Thursday that it has approved Eli Lilly and Co.'s erectile dysfunction drug Cialis to be used in treating symptoms tied to a condition that leads to an enlarged prostate. The FDA said common symptoms of benign prostatic hyperplasia include difficulty starting urination, a weak urine stream and a sudden urge to urinate and more frequent urination. Regulators approved Cialis in 2003 as an erectile dysfunction treatment, and it has since become one of Indianapolis-based Lilly's best-selling drugs. Cialis brought in $477.2 million in sales in the second quarter and $1.7 billion last year. Additional revenue from a new use for Cialis will be welcomed. Lilly will lose U.S. patent protection for its top-selling drug, the antipsychotic Zyprexa, later this month, and analysts expect sales to ... Read more

Related support groups: Cialis, Benign Prostatic Hyperplasia (BPH)

FDA OKs Impotence Drug Cialis to Treat Enlarged Prostate

Posted 7 Oct 2011 by Drugs.com

THURSDAY, Oct. 6 – The U.S. Food and Drug Administration announced late Thursday that it had approved using the erectile dysfunction drug Cialis as a treatment for enlarged prostate. According to the U.S. National Institutes of Health, enlarged prostate – clinically known as benign prostatic hyperplasia (BPH) – is a "common part of aging" for men. In fact, the NIH estimates that "more than half of men in their 60s, and as many as 90 percent in their 70s and 80s, have some symptoms of BPH." The condition often leads to urinary incontinence and can raise the odds for urinary tract infections and even kidney damage. "BPH can have a big impact on a patient's quality of life," Scott Monroe, director of the division of reproductive and urologic products in the FDA's Center for Drug Evaluation and Research, said in an agency news release. "A large number of older men have symptoms of BPH. ... Read more

Related support groups: Erectile Dysfunction, Cialis, Flomax, Benign Prostatic Hyperplasia (BPH), Urinary Incontinence, Avodart, Rapaflo, Cardura, Jalyn, Proscar, Hytrin, Uroxatral

Cialis Approved to Treat Enlarged Prostate

Posted 7 Oct 2011 by Drugs.com

FRIDAY, Oct. 7 – The erectile dysfunction drug Cialis (tadalafil) has received new approval from the U.S. Food and Drug Administration to treat benign prostatic hyperplasia (BPH), the medical term for an enlarged prostate. Symptoms of BPH frequently include difficulty urinating, a sudden urge to urinate, and an increase in having to urinate, notably at night. The drug was evaluated among men with BPH in three trials. Those who took 5 milligrams of Cialis once daily showed significant reduction in symptoms of BPH, the FDA said in a news release. The third trial involved men with BPH who also had been diagnosed with erectile dysfunction. Men who take a class of drugs called nitrates, including nitroglycerin, shouldn't take Cialis in tandem, since the combination could lead to an unsafe drop in blood pressure, the FDA said. The agency made a similar warning about taking Cialis along with ... Read more

Related support groups: Cialis, Benign Prostatic Hyperplasia (BPH)

Drugs Like Viagra Linked to Higher Rates of STDs

Posted 6 Jul 2010 by Drugs.com

MONDAY, July 5 – Middle-aged and older men who take erectile dysfunction drugs such as Viagra are more likely to have sexually transmitted diseases, a new study of more than 1.4 million men finds. Researchers at Massachusetts General Hospital and the University of Southern California say the fault lies not with the drugs but rather the high risk behaviors of the men who request them. And doctors should counsel these patients about safe sex practices, they said. Small studies of men who have sex with men have associated the use of ED drugs with higher risk behaviors and increased rates of STDs, but this report, published in the July 6 issue of the Annals of Internal Medicine, is said to be the first to examine the relationship between ED drugs and STD risk in a large, representative sample of privately insured older men. The researchers had no way of knowing how many of the men were ... Read more

Related support groups: Viagra, Erectile Dysfunction, Cialis, Levitra, Sexually Transmitted Diseases

Viagra Linked to Hearing Loss

Posted 19 May 2010 by Drugs.com

WEDNESDAY, May 19 – The erectile dysfunction drug Viagra, and possibly other similar medications, may prompt long-term hearing loss among users, a new study suggests. In the May 18 issue of the Archives of Otolaryngology – Head and Neck Surgery, researchers from the University of Alabama at Birmingham discuss evidence supporting an association between the onset of hearing problems and Viagra. The medication is one of the so-called class of phosphodiesterase type 5 inhibitors (PDE-5i), which also includes Cialis and Levitra. The finding follows the 2007 decision by the U.S. Food and Drug Administration to adjust labeling for such medications to more prominently display warnings about hearing loss risks. The move stemmed from reports that year regarding sudden hearing loss among users of these drugs. "It appears from these findings that the current government warning regarding hearing ... Read more

Related support groups: Viagra, Cialis, Levitra, Sildenafil, Tadalafil, Revatio, Vardenafil

Guidelines Urge Use of Erectile Dysfunction Drugs

Posted 2 Dec 2009 by Drugs.com

THURSDAY, Oct. 22 – Doctors should prescribe oral phosphodiesterase type 5 (PDE-5) inhibitor drugs, such as Viagra, Cialis and Levitra, for men with erectile dysfunction, unless the patient is on nitrate therapy, according to a clinical practice guideline issued by the American College of Physicians. The type of erectile dysfunction (ED) drug prescribed should be based on the individual preferences of patients, including cost of medication, ease of use and types of side effects, the authors noted. "The evidence is insufficient to compare the effectiveness or adverse effects of different PDE-5 inhibitors for the treatment of ED because there were only a few head-to-head trials," guideline lead author Dr. Amir Qaseem, senior medical associate with the ACP, said in a news release. Qaseem and colleagues analyzed the findings of 130 studies that evaluated PDE-5 inhibitors alone or combined. ... Read more

Related support groups: Viagra, Erectile Dysfunction, Cialis, Levitra

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Erectile Dysfunction, Benign Prostatic Hyperplasia (BPH)

Cialis Patient Information at Drugs.com